Immunological Parameters for Assessing the In Vitro Safety and Efficacy of Allergoid Mixtures for Immunotherapy
These findings support the use of DPmixE as a promising formulation for allergen immunotherapy, combining stability, reduced enzymatic activity, and enhanced immunological stimulation, while preserving in vitro safety and efficacy comparable to separated depigmented-polymerized extracts.
Authors
- David Calzada
- Cristina Galache (ORCID: https://orcid.org/0000-0002-0274-2863)
- J M Beitia
- Raquel Moya (ORCID: https://orcid.org/0000-0002-0741-683X)
- David González‐de‐Olano (ORCID: https://orcid.org/0000-0001-6653-4900)
- Jerónimo Carnés (ORCID: https://orcid.org/0000-0003-4050-2577)
- Javier Domínguez‐Ortega (ORCID: https://orcid.org/0000-0002-5397-2327)
- Nuria Parody
- Ana Renshaw-Calderón
Institutions
- Hospital Universitario de Guadalajara (ES)
- Hospital Universitario Ramón y Cajal (ES)
Publication Details
- Journal
- Journal of Investigational Allergology and Clinical Immunology
- Published
- 2025-04-08
- DOI
- https://doi.org/10.18176/jiaci.1061
- Citations
- 1
- Primary Topic
- Allergic Rhinitis and Sensitization
- Type
- article
- Field-Weighted Citation Impact
- 1.62